GO:0035770 ribonucleoprotein granule: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035770 ribonucleoprotein granule describes membrane-less compartments that concentrate RNAs and RNA-binding proteins to control RNA fate.
• Stress granules and P-bodies are the best-studied ribonucleoprotein granules; their assembly is driven by multivalent RNA-protein and protein-protein interactions.
• Core nucleators such as G3BP1 and DDX6 seed granule formation and determine composition and docking behavior.
• Ribonucleoprotein granules are cleared by chaperone-dependent disassembly and V-ATPase-linked pathways, and failure of clearance is linked to aging and neurodegeneration.
• Proteotoxic stress and RNA damage can trigger distinct granule subtypes that compartmentalize damaged RNA and modulate immune evasion.
• CRISPR knockout, knock-in, and overexpression models are essential to test causality of granule components in disease.
Description
Ribonucleoprotein granules (GO:0035770) are non-membrane-bound assemblies of RNA and RNA-binding proteins that form in the cytoplasm and nucleus to regulate RNA processing, storage, translation, and decay. They are dynamic structures that condense in response to stress, developmental cues, and signaling changes, and they are increasingly recognized as central organizers of post-transcriptional gene regulation. Because they lack a lipid bilayer, their assembly and disassembly are governed by weak, multivalent interactions among proteins and RNAs, which makes them sensitive to cellular conditions and disease-associated mutations. Researchers study ribonucleoprotein granules to understand how cells compartmentalize RNA without membranes, how stress responses are coordinated, and how granule dysfunction contributes to neurodegeneration, cancer, and immune disorders. The field has moved from descriptive imaging to mechanistic dissection using proximity labeling, proteomics, and CRISPR-based perturbation, revealing both shared and subtype-specific components.
ribonucleoprotein granule At A Glance
| GO ID | GO:0035770 |
|---|---|
| GO term | ribonucleoprotein granule |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Compartmentalization of RNA and RNA-binding proteins for post-transcriptional regulation |
| Key subtypes | Stress granules, P-bodies, RNA damage granules |
| Core nucleators | G3BP1, DDX6, DHX9 |
| Assembly principle | Multivalent RNA-protein and protein-protein interactions |
| Clearance pathways | Chaperone-mediated disassembly, V-ATPase/NCOA7-linked clearance |
What Is GO:0035770?
GO:0035770 ribonucleoprotein granule is a cellular component consisting of a membrane-less, microscopically visible assembly enriched in RNA and RNA-binding proteins. These granules concentrate specific transcripts and proteins to regulate RNA stability, translation, and localization, and they can rapidly assemble or disassemble in response to cellular signals or stress.
Why Is ribonucleoprotein granule Important in Cell Biology?
Ribonucleoprotein granules are important because they allow cells to rapidly reorganize RNA metabolism without membrane trafficking, and their dysfunction is increasingly linked to human disease. They modulate translation and RNA decay during stress, influence immune cell exhaustion and immune evasion, and contribute to neurodegeneration when they persist or mislocalize. Understanding their assembly, composition, and clearance provides mechanistic insight into aging, cancer, and neurological disorders, and offers targets for therapeutic intervention.
• They regulate mRNA translation and stability during stress and recovery.
• They compartmentalize damaged RNA to prevent translation of aberrant transcripts.
• They modulate T cell exhaustion and immune evasion in cancer.
• They are implicated in neurodegenerative diseases such as ALS and frontotemporal dementia.
• They contribute to ovarian aging through impaired clearance mechanisms.
• They serve as hubs for RNA-binding proteins with disease-linked mutations.
• They can be targeted by proximity labeling to map dynamic interactomes.
• They influence P-body and stress granule docking and composition.
• They provide a model for studying membrane-less organelle biophysics.
• They are tractable by CRISPR screens to identify regulators.
What Happens During ribonucleoprotein granule?
Nucleation and seeding
In simple terms: A few key proteins and RNAs start clumping together to form a seed.
Ribonucleoprotein granule assembly begins with nucleation driven by multivalent interactions among RNA-binding proteins and specific RNAs. G3BP1 is a core nucleator for stress granules, and its RNA-binding and protein-interaction domains are required for seeding. DDX6 similarly modulates P-body and stress granule assembly, influencing composition and docking. These nucleation events are concentration-dependent and can be triggered by stress-induced changes in RNA-protein interactions.
Growth and maturation
In simple terms: The seed recruits more proteins and RNAs, growing into a visible granule.
Once nucleated, granules grow by recruiting additional RNA-binding proteins and transcripts. Proximity labeling studies have revealed dynamic changes in the granule proteome during maturation, including recruitment of chaperones and clearance factors. The composition is not fixed; different stress conditions can produce distinct granule subtypes, such as DHX9 stress granules that specifically compartmentalize damaged RNA. Maturation involves reorganization of internal interactions and can lead to docking with other granules like P-bodies.
Function and RNA fate control
In simple terms: Inside the granule, RNAs are stored, translated, or degraded depending on the cell's needs.
Ribonucleoprotein granules regulate RNA fate by concentrating specific transcripts and enzymes. Stress granules generally sequester mRNAs to inhibit translation during stress, while P-bodies are sites of RNA decay. DHX9 stress granules compartmentalize damaged RNA, preventing translation of aberrant transcripts. The balance between storage and decay is influenced by granule composition and crosstalk with other RNA processing bodies.
Disassembly and clearance
In simple terms: When stress ends, the granule must be taken apart and cleared away.
Granule disassembly requires chaperone activity and active clearance pathways. V-ATPase-interacting protein NCOA7 mediates stress granule clearance, and its dysfunction impairs clearance and accelerates ovarian aging. Proximity labeling has identified additional disassembly factors, including chaperones and ATPases that remodel granule interactions. Failure of clearance leads to persistent granules, which are toxic in neurodegenerative contexts.
Stress-specific granule subtypes
In simple terms: Different stresses can create different types of granules with specialized jobs.
Not all ribonucleoprotein granules are the same. Proteotoxic stress drives a stress response that can lead to T cell exhaustion and immune evasion, involving granule-mediated regulation. RNA damage triggers DHX9 stress granules that are distinct from canonical stress granules and specifically handle damaged RNA. These subtypes highlight the functional specialization of ribonucleoprotein granules in response to distinct cellular insults.
Key Genes Involved in GO:0035770 ribonucleoprotein granule
The following genes encode core components and regulators of ribonucleoprotein granules, with established roles in assembly, composition, and clearance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| G3BP1 | Core nucleator of stress granules | Knockout abolishes stress granule formation; disease links |
| DDX6 | Modulates P-body and stress granule assembly and docking | Regulates granule composition and crosstalk |
| DHX9 | Forms RNA damage-induced stress granules | Compartmentalizes damaged RNA |
| NCOA7 | Mediates stress granule clearance via V-ATPase interaction | Linked to ovarian aging |
| V-ATPase subunits | Interact with NCOA7 for granule clearance | Clearance pathway components |
| TIA1 | Stress granule marker and RNA-binding protein | Neurodegeneration-linked |
| PABP | Poly(A)-binding protein enriched in granules | Translation regulation |
| eIF4E | Translation initiation factor in granules | Stress response |
| eIF4G | Translation initiation factor in granules | Stress response |
| ATXN2 | RNA-binding protein linked to ALS | Granule persistence in disease |
| FUS | RNA-binding protein forming granules | ALS/FTD mutations |
| TDP-43 | RNA-binding protein in granules | ALS/FTD pathology |
| hnRNPA1 | RNA-binding protein in granules | Neurodegeneration |
| CAPRIN1 | Stress granule component | Assembly regulation |
| USP10 | Deubiquitinase regulating granule dynamics | Clearance and stress response |
| HSP70 | Chaperone involved in disassembly | Granule clearance |
| VCP/p97 | ATPase in granule disassembly | Clearance pathway |
| SQSTM1/p62 | Autophagy receptor linked to granule clearance | Clearance and disease |
How Is ribonucleoprotein granule Regulated?
Ribonucleoprotein granule assembly and disassembly are regulated by signaling pathways that sense stress and nutrient status. The integrated stress response, mTOR inhibition, and proteotoxic stress can promote granule formation. Clearance is regulated by chaperones, ATPases, and V-ATPase-associated factors such as NCOA7. Post-translational modifications, including ubiquitination and deubiquitination by USP10, modulate granule dynamics. RNA damage can trigger specific granule subtypes through DHX9. These regulatory layers ensure that granules form transiently and are removed when no longer needed.
ribonucleoprotein granule and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| G3BP1 | Neurodegeneration, stress granule formation | Knockout and point-mutation cell lines |
| NCOA7 | Ovarian aging, granule clearance | Knockout and overexpression models |
| DHX9 | RNA damage response | Knockout and tagged knock-in |
| FUS | ALS/FTD | Patient-derived iPSCs with point mutations |
| TDP-43 | ALS/FTD | Knock-in and overexpression models |
Neurodegenerative diseases
Persistent or mislocalized ribonucleoprotein granules are a hallmark of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Mutations in RNA-binding proteins such as FUS, TDP-43, and ATXN2 promote granule formation and impair clearance, leading to toxic protein aggregates. Stress granule markers co-localize with pathological inclusions in patient tissues, and experimental models show that granule persistence contributes to neuronal death.
Cancer and immune evasion
Proteotoxic stress in the tumor microenvironment drives a stress response that leads to T cell exhaustion and immune evasion, in which ribonucleoprotein granules play a central role. Granule-mediated regulation of RNA fate can support cancer cell survival under stress and modulate immune recognition. Targeting granule components may enhance immunotherapy efficacy.
Aging and ovarian function
Impaired clearance of stress granules contributes to ovarian aging. NCOA7, a V-ATPase-interacting protein, mediates stress granule clearance, and its loss leads to granule accumulation and accelerated ovarian aging in models. This links granule homeostasis to reproductive aging and suggests that enhancing clearance could mitigate age-related decline.
RNA damage and genome stability
DHX9 stress granules compartmentalize damaged RNA, preventing translation of aberrant transcripts. Defects in this pathway can lead to accumulation of damaged RNA and cellular dysfunction. This highlights a protective role for specific granule subtypes in maintaining RNA quality control.
From ribonucleoprotein granule-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of G3BP1 abolish stress granule formation? | G3BP1 knockout cell line |
| Does NCOA7 mutation impair granule clearance? | NCOA7 point-mutation knock-in |
| How does DDX6 modulate granule docking? | DDX6 knockout and tagged knock-in |
| Does DHX9 granule formation require RNA damage? | DHX9 knockout and overexpression |
| Can granule persistence be reversed by chaperone overexpression? | HSP70 overexpression |
| Does proteotoxic stress drive T cell exhaustion via granules? | Primary T cells with granule gene knockout |
How to Study the ribonucleoprotein granule Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Granule number, size, dynamics | Live-cell imaging of G3BP1 |
| FRAP | Turnover of granule components | Assembly/disassembly kinetics |
| µMap proximity labeling | Proteome of granules in living cells | Disassembly factors |
| Mass spectrometry | Protein composition | Granule isolation |
| RNA-seq | Transcripts enriched in granules | RNA recruitment |
| Ribo-seq | Translation efficiency | Stress response |
| CRISPR knockout screen | Genes required for granule formation | Regulator discovery |
| Immunofluorescence | Co-localization with markers | Disease tissue analysis |
Imaging and live-cell tracking
Fluorescence microscopy of GFP-tagged granule markers (e.g., G3BP1, DDX6) allows real-time tracking of assembly and disassembly. Live-cell imaging combined with FRAP measures dynamics and turnover.
Proximity labeling and proteomics
µMap proximity labeling in living cells identifies granule-associated proteins and reveals disassembly mechanisms. Mass spectrometry of isolated granules provides composition data.
RNA sequencing and Ribo-seq
RNA-seq of granule-enriched fractions identifies transcripts recruited to granules, while Ribo-seq measures translation changes upon granule formation or disruption.
CRISPR screens
Genome-wide CRISPR knockout screens can identify regulators of granule assembly and clearance. Validated hits can be studied with point mutations and knock-ins.
How CRISPR Can Be Used to Study GO:0035770 ribonucleoprotein granule
Knockout
CRISPR knockout of core granule genes such as G3BP1 or DDX6 abolishes or alters granule formation, providing causal evidence for their roles. Knockout cell lines are used to test stress responses and disease phenotypes.
Point Mutation
Point mutations in granule-associated genes (e.g., NCOA7, FUS) can mimic disease-associated variants and reveal effects on granule clearance or persistence. Knock-in of specific mutations allows precise functional dissection.
Knock-in
Tagged knock-in of granule proteins (e.g., GFP-G3BP1) enables live-cell imaging and proteomics without overexpression artifacts. Knock-in of disease mutations provides physiologically relevant models.
Overexpression
Overexpression of granule components or chaperones can drive granule formation or enhance clearance, respectively. This approach tests sufficiency and can rescue loss-of-function phenotypes.
How EDITGENE Supports ribonucleoprotein granule Research
Researchers studying ribonucleoprotein granule-related genes often need to determine whether a candidate gene is causally involved in granule assembly, composition, or clearance. EDITGENE provides CRISPR-based cell models and screening services to accelerate this mechanistic work.
Contact EDITGENE today to design your custom CRISPR model for ribonucleoprotein granule research.
Frequently Asked Questions About ribonucleoprotein granule
What is GO:0035770 ribonucleoprotein granule?
GO:0035770 describes a membrane-less cellular compartment enriched in RNA and RNA-binding proteins that regulates RNA fate.
What genes are involved in ribonucleoprotein granule formation?
Key genes include G3BP1, DDX6, DHX9, and NCOA7, among others.
How are stress granules related to ribonucleoprotein granules?
Stress granules are a subtype of ribonucleoprotein granules that form under stress to sequester mRNAs.
What diseases are linked to ribonucleoprotein granules?
They are linked to neurodegeneration, cancer immune evasion, and ovarian aging.
How can I study ribonucleoprotein granules in the lab?
Common methods include fluorescence microscopy, proximity labeling, RNA-seq, and CRISPR screens.
What is the role of G3BP1 in stress granules?
G3BP1 is a core nucleator required for stress granule assembly.
How does NCOA7 affect stress granule clearance?
NCOA7 interacts with V-ATPase to mediate stress granule clearance, and its loss impairs clearance.
Can CRISPR knockout help study granule function?
Yes, knockout of granule genes such as G3BP1 or DDX6 abolishes or alters granule formation, providing causal evidence.
What is the difference between stress granules and P-bodies?
Stress granules primarily store mRNA, while P-bodies are sites of RNA decay; they can dock and exchange components.
How does DHX9 contribute to RNA damage response?
DHX9 forms stress granules that compartmentalize damaged RNA to prevent translation of aberrant transcripts.
Conclusion
Ribonucleoprotein granules (GO:0035770) are dynamic, membrane-less compartments that orchestrate RNA fate and are central to stress responses, aging, and disease. Their assembly, composition, and clearance are governed by multivalent interactions and regulated by signaling pathways and chaperones. Dysfunction of these granules contributes to neurodegeneration, cancer immune evasion, and reproductive aging, making them attractive targets for therapeutic intervention. CRISPR-based models and advanced proteomics will continue to unravel the mechanistic details and identify new regulators.
References
- 1. Dong T et al.. 2025. Stress granule clearance mediated by V-ATPase-interacting protein NCOA7 mitigates ovarian aging.. Nat Aging 5(8):1548-1567 PMID: 40745099
- 2. Pan CR et al.. 2025. µMap proximity labeling in living cells reveals stress granule disassembly mechanisms.. Nat Chem Biol 21(4):490-500 PMID: 39215100
- 3. Ripin N et al.. 2023. Formation, function, and pathology of RNP granules.. Cell 186(22):4737-4756 PMID: 37890457
- 4. Cui Q et al.. 2024. Friend or foe: The role of stress granule in neurodegenerative disease.. Neuron 112(15):2464-2485 PMID: 38744273
- 5. Wang Y et al.. 2025. Proteotoxic stress response drives T cell exhaustion and immune evasion.. Nature 647(8091):1025-1035 PMID: 41034580
- 6. Zhou Y et al.. 2024. RNA damage compartmentalization by DHX9 stress granules.. Cell 187(7):1701-1718.e28 PMID: 38503283
- 7. Guo J et al.. 2024. Application of stress granule core element G3BP1 in various diseases: A review.. Int J Biol Macromol 282(Pt 5):137254 PMID: 39515684
- 8. Ripin N et al.. 2024. DDX6 modulates P-body and stress granule assembly, composition, and docking.. J Cell Biol 223(6) PMID: 38536035
